Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DxS Ltd.

Stephen Little1

  • 1DxS Ltd, 48 Grafton St., Manchester, M13 9XX, UK. stephen.little@dxsgenotyping.com

Pharmacogenomics
|January 9, 2003
PubMed
Summary
This summary is machine-generated.

DxS provides genetic analysis services to support the pharmaceutical industry in drug discovery and development. Their strategy enables pharmacogenomics and personalized medicine through fee-for-service support and a global diagnostic laboratory alliance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric abusive spine trauma: a review of whole-spine imaging essentials.

Pediatric radiology·2026
Same author

Pediatric low-grade epilepsy-associated tumors (LEATS): neuroimaging review and genetics update.

Pediatric radiology·2026
Same author

Radiation Realities: Radiation Safety Practices and Awareness Among Interventional Echocardiographers in the United States.

Structural heart : the journal of the Heart Team·2026
Same author

Association of secondary mitral regurgitation and right ventricular dysfunction among patients with non-ischaemic cardiomyopathy.

European heart journal. Cardiovascular Imaging·2024
Same author

Aortic Valve Calcium Score in Addition to Dobutamine Stress Echocardiography for Low-Flow, Low-Gradient Aortic Stenosis Assessment.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2023
Same author

Systematic Approach to Pediatric Macrocephaly.

Radiographics : a review publication of the Radiological Society of North America, Inc·2023
Same journal

Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial.

Pharmacogenomics·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
See all related articles

Area of Science:

  • Pharmacogenomics
  • Genetic Diagnostics
  • Pharmaceutical Industry

Background:

  • DxS operates at the intersection of genetic diagnostics and the pharmaceutical sector.
  • The company aims to facilitate the adoption of pharmacogenomics within healthcare.

Purpose of the Study:

  • To outline DxS's strategy for enabling pharmacogenomics through genetic analysis services.
  • To highlight the company's role in supporting drug discovery, development, and marketing.
  • To introduce the concept of personalized medicine enabled by genetic insights.

Main Methods:

  • Provision of fee-for-service genetic analysis.
  • Focus on customer, technical, and logistical support.
  • Development of the Genetwork global alliance of diagnostic service laboratories.

Related Experiment Videos

Main Results:

  • Services support clinical trials under stringent quality systems.
  • Facilitation of drug discovery, development, and marketing.
  • Enabling personalized medicine through diagnostic genotyping.

Conclusions:

  • DxS's approach supports the integration of pharmacogenomics into healthcare.
  • The company's services and global alliance are key to implementing personalized medicine.
  • A focus on quality and support is central to DxS's business model.